HIGHEST PERFORMANCES HOLDING(NASDAQ:HPH) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to HPH. HPH was compared to 223 industry peers in the Capital Markets industry. No worries on liquidiy or solvency for HPH as it has an excellent financial health rating, but there are worries on the profitability. HPH is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year HPH has reported negative net income.

HPH had a positive operating cash flow in the past year.

HPH had negative earnings in each of the past 5 years.

In the past 5 years HPH reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -7.57%, HPH is doing worse than 87.00% of the companies in the same industry.

The Return On Equity of HPH (-24.33%) is worse than 84.75% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7.57%
ROE	-24.33%
ROIC	N/A

ROA(3y)-12.12%

ROA(5y)-10.77%

ROE(3y)-21.75%

ROE(5y)-17.73%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of HPH (40.70%) is worse than 64.13% of its industry peers.

In the last couple of years the Gross Margin of HPH has declined.

The Profit Margin and Operating Margin are not available for HPH so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	40.7%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.86%

GM growth 5Y-14.09%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, HPH has about the same amount of shares outstanding.

The number of shares outstanding for HPH has been increased compared to 5 years ago.

The debt/assets ratio for HPH is higher compared to a year ago.

2.2 Solvency

HPH has an Altman-Z score of 0.63. This is a bad value and indicates that HPH is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 0.63, HPH is not doing good in the industry: 60.99% of the companies in the same industry are doing better.

HPH has a debt to FCF ratio of 1.84. This is a very positive value and a sign of high solvency as it would only need 1.84 years to pay back of all of its debts.

With an excellent Debt to FCF ratio value of 1.84, HPH belongs to the best of the industry, outperforming 83.86% of the companies in the same industry.

HPH has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.

HPH's Debt to Equity ratio of 0.07 is amongst the best of the industry. HPH outperforms 81.17% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	1.84
Altman-Z	0.63

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

HPH has a Current Ratio of 2.80. This indicates that HPH is financially healthy and has no problem in meeting its short term obligations.

HPH has a better Current ratio (2.80) than 80.27% of its industry peers.

HPH has a Quick Ratio of 2.80. This indicates that HPH is financially healthy and has no problem in meeting its short term obligations.

Looking at the Quick ratio, with a value of 2.80, HPH belongs to the top of the industry, outperforming 80.27% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.8
Quick Ratio	2.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HPH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -230.25%.

Looking at the last year, HPH shows a very strong growth in Revenue. The Revenue has grown by 967.12%.

HPH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.29% yearly.

EPS 1Y (TTM)-230.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-831.34%

Revenue 1Y (TTM)967.12%

Revenue growth 3Y83.7%

Revenue growth 5Y42.29%

Sales Q2Q%2476.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HPH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, HPH is valued cheaper than 84.75% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	5.06
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for HPH!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HIGHEST PERFORMANCES HOLDING

NASDAQ:HPH (3/7/2025, 8:00:01 PM)

After market: 0.1501 0 (-0.13%)

0.1503

0 (-2.02%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)03-04 2024-03-04/amc

Earnings (Next)N/A N/A

Inst Owners0.03%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap37.33M

AnalystsN/A

Price TargetN/A

Short Float %0.01%

Short Ratio0.02

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.22
P/FCF	5.06
P/OCF	4.68
P/B	0.2
P/tB	0.4
EV/EBITDA	N/A

EPS(TTM)-0.21

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.03

FCFY19.78%

OCF(TTM)0.03

OCFY21.37%

SpS0.68

BVpS0.74

TBVpS0.37

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.57%
ROE	-24.33%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	40.7%
FCFM	4.38%

ROA(3y)-12.12%

ROA(5y)-10.77%

ROE(3y)-21.75%

ROE(5y)-17.73%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-19.86%

GM growth 5Y-14.09%

F-Score4

Asset Turnover0.29

Health

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	1.84
Debt/EBITDA	N/A
Cap/Depr	7.27%
Cap/Sales	0.35%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.8
Quick Ratio	2.8
Altman-Z	0.63

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)45.7%

Cap/Depr(5y)105.98%

Cap/Sales(3y)1.66%

Cap/Sales(5y)2.5%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-230.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-831.34%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)967.12%

Revenue growth 3Y83.7%

Revenue growth 5Y42.29%

Sales Q2Q%2476.18%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-4.98%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y296.13%

FCF growth 3YN/A

FCF growth 5Y-10.53%

OCF growth 1Y327.63%

OCF growth 3YN/A

OCF growth 5Y-10.05%

HIGHEST PERFORMANCES HOLDING (HPH) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens